Synthesis, structural characterization and radiochemistry of di- and tricarbonyl Re(I) and 99mTc(I) complexes with 8-hydroxyquinoline or 8-mercaptoquinoline and triphenylphosphine

Add time:09/04/2019    Source:sciencedirect.com

In this work, we focused on the development of mixed ligand technetium and rhenium complexes of the general formula fac-[99mTc/Re(CO)3(PPh3)(ox/tq)] and cis, trans-[99mTc/Re(CO)2(PPh3)2(ox/tq)] where 8-hydroxyquinoline (oxH) and 8-mercaptoquinoline (tqH) act as [NO] and [NS] bidentate ligands. The synthesis of rhenium complexes fac-[Re(CO)3(PPh3)(ox/tq)] Re3/Re4 was conducted by reacting oxH or tqH and triphenylphosphine with fac-(NEt4)2[Re(CO)3Br3] (1) or by reacting triphenylphosphine with the dimer complexes fac-[Re(CO)3(ox/tq)]2 Re1/Re2. The synthesis of the rhenium complexes cis, trans-[Re(CO)2(PPh3)2(ox/tq)] Re5/Re6 was conducted either by reacting 1 with oxH/tqH in equimolar amounts and triphenylphosphine in excess or by reacting oxH/tqH with the precursor mer, trans-[Re(CO)3(PPh3)2Cl]. All the complexes were characterized by IR, NMR and X-ray crystallography. The analogous 99mTc complexes were prepared by reacting oxH/tqH and PPh3 with the precursor fac-[99mTc(CO)3(OH2)3]+ (2). When the reaction mixture was left at rt for 2 h the monophosphino complexes fac-[99mTc(CO)3(PPh3)(ox/tq)] 99mTc3/99mTc4 were formed, while by applying heating at 75 °C for 30 min the dicarbonyl complexes cis, trans-[99mTc(CO)2(PPh3)2(ox/tq)] 99mTc5/99mTc6 were formed quantitatively. The 99mTc complexes were identified by HPLC chromatographic comparison with the analogous rhenium complexes and their stability was studied.

We also recommend Trading Suppliers and Manufacturers of TRIPHENYLPHOSPHINE HYDROCHLORIDE (cas 15647-89-9). Pls Click Website Link as below: cas 15647-89-9 suppliers

Prev:Synthesis of a rhodium(III) triphenylphosphine complex via CS bond cleavage of an azo-thioether ligand: X-ray structure, electrochemistry and catalysis towards transfer hydrogenation of ketones
Next:Synthesis, crystal structure, and absolute configuration of the enantiomers of chiral drug xibenolol hydrochloride)